Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques

Journal of Biological Chemistry

Volumn 287, Issue 18, 2012, Pages 14897-14911

  Mencarelli, Chiara ^a   Bode, Gerard H ^a   Losen, Mario ^a   Kulharia, Mahesh ^b   Molenaar, Peter C ^a   Veerhuis, Robert ^c   Steinbusch, Harry W M ^a   De Baets, Marc H ^a,d   Nicolaes, Gerry A F ^b   Martinez Martinez, Pilar ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOID DEPOSITS; AMYLOID PLAQUES; ANTIGEN-BINDING; BASEMENT MEMBRANE; COLOCALIZE; DECAMERS; EXTRACELLULAR MATRICES; HUMAN SERUM; INNATE IMMUNE SYSTEMS; PATHOLOGICAL CONDITIONS; PENTAMERS; SERUM AMYLOID P;

ANTIGENS; BLOOD; BUILDINGS; NEURODEGENERATIVE DISEASES; PHYSIOLOGY;

GLYCOPROTEINS;

BINDING PROTEIN; CARRIER PROTEIN; CERAMIDE TRANSPORTER; COLLAGEN TYPE 4; GOODPASTURE ANTIGEN BINDING PROTEIN; LAMININ; PROTEIN SERINE THREONINE KINASE; SERUM AMYLOID P; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BASEMENT MEMBRANE; BLOOD LEVEL; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; MICE; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SERUM AMYLOID P-COMPONENT;

EID: 84860365186     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.299545     Document Type: Article

References (52)

1. Ashton, A. W., Boehm, M. K., Gallimore, J. R., Pepys, M. B., and Perkins, S. J. (1997) Pentameric and decameric structures in solution of serum amyloid P component by x-ray and neutron scattering and molecular modeling analyses. J. Mol. Biol. 272, 408-422
2. Cathcart, E. S., Comerford, F. R., and Cohen, A. S. (1965) Immunologic Studies on a Protein Extracted from Human Secondary Amyloid. N. Engl. J. Med. 273, 143-146
3. Schwab, C., and McGeer, P. L. (2008) Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J. Alzheimers Dis. 13, 359-369
4. Veerhuis, R., Van Breemen, M. J., Hoozemans, J. M., Morbin, M., Ouladhadj, J., Tagliavini, F., and Eikelenboom, P. (2003) Amyloid β plaqueassociated proteins C1q and SAP enhance the Aβ1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol. 105, 135-144
5. Tennent, G. A., Lovat, L. B., and Pepys, M. B. (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc. Natl. Acad. Sci. U.S.A. 92, 4299-4303
6. Painter, R. H., De Escallón, I., Massey, A., Pinteric, L., and Stern, S. B. (1982) The structure and binding characteristics of serum amyloid protein (9.5S α 1-glycoprotein). Ann. N.Y. Acad. Sci. 389, 199-215
7. 2+-dependent binding of human serum amyloid P component to Alzheimer β-amyloid peptide. J. Biol. Chem. 270, 10392-10394
8. 2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate. J. Biol. Chem. 262, 1456-1460
9. Zahedi, K. (1996) Characterization of the binding of serum amyloid P to type IV collagen. J. Biol. Chem. 271, 14897-14902
10. Zahedi, K. (1997) Characterization of the binding of serum amyloid P to laminin. J. Biol. Chem. 272, 2143-2148
11. Nielsen, E. H., Sørensen, I. J., Vilsgaard, K., Andersen, O., and Svehag, S. E. (1994) Calcium-enhanced aggregation of serum amyloid P component and its inhibition by the ligands heparin and heparan sulfate. An electron microscopic and immunoelectrophoretic study. APMIS 102, 420-426
12. de Beer, F. C., Baltz, M. L., Holford, S., Feinstein, A., and Pepys, M. B. (1981) Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J. Exp. Med. 154, 1134-1139
13. Bristow, C. L., and Boackle, R. J. (1986) Evidence for the binding of human serum amyloid P component to Clq and Fab γ. Mol. Immunol. 23, 1045-1052
14. Hutchcraft, C. L., Gewurz, H., Hansen, B., Dyck, R. F., and Pepys, M. B. (1981) Agglutination of complement-coated erythrocytes by serum amyloid P component. J. Immunol. 126, 1217-1219
15. García de Frutos, P., Härdig, Y., and Dahlbäck, B. (1995) Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270, 26950-26955
16. Ying, S. C., Gewurz, A. T., Jiang, H., and Gewurz, H. (1993) Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J. Immunol. 150, 169-176
17. Dyck, R. F., Lockwood, C. M., Kershaw, M., McHugh, N., Duance, V. C., Baltz, M. L., and Pepys, M. B. (1980) Amyloid P-component is a constituent of normal human glomerular basement membrane. J. Exp. Med. 152, 1162-1174
18. Tseng, J., and Mortensen, R. F. (1986) Binding specificity of mouse serum amyloid P-component for fibronectin. Immunol. Invest. 15, 749-761
19. Stanton, M. C., and Tange, J. D. (1958) Goodpasture's syndrome (pulmonary hemorrhage associated with glomerulonephritis). Australas. Ann. Med. 7, 132-144
20. Raya, A., Revert, F., Navarro, S., and Saus, J. (1999) Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human Goodpasture antigen. J. Biol. Chem. 274, 12642-12649
21. Mencarelli, C., Losen, M., Hammels, C., De Vry, J., Hesselink, M. K., Steinbusch, H. W., De Baets, M. H., and Martínez-Martínez, P. (2010) The ceramide transporter and the Goodpasture antigen binding protein. One protein, one function? J. Neurochem. 113, 1369-1386
22. Revert, F., Ventura, I., Martínez-Martínez, P., Granero-Moltó, F., Revert-Ros, F., Macías, J., and Saus, J. (2008) Goodpasture antigen-binding protein is a soluble exportable protein that interacts with type IV collagen. Identification of novel membrane-bound isoforms. J. Biol. Chem. 283, 30246-30255
23. Saus, J. V., and Revert, F. M. (May 3, 2011) Goodpasture antigen-binding protein and its detection, U.S. Patent no. US7935492
24. Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., and Nishijima, M. (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426, 803-809
25. Raya, A., Revert-Ros, F., Martinez-Martinez, P., Navarro, S., Rosello, E., Vieites, B., Granero, F., Forteza, J., and Saus, J. (2000) Goodpasture antigen-binding protein, the kinase that phosphorylates the Goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J. Biol. Chem. 275, 40392-40399
26. Jönsson, U., Fägerstam, L., Ivarsson, B., Johnsson, B., Karlsson, R., Lundh, K., Löfås, S., Persson, B., Roos, H., and Rönnberg, I. (1991) Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. BioTechniques 11, 620-627
27. Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P., and Duhr, S. (2011) Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 9, 342-353
28. Baaske, P., Wienken, C. J., Reineck, P., Duhr, S., and Braun, D. (2010) Optical thermophoresis for quantifying the buffer dependence of aptamer binding. Angew. Chem. Int. Ed. Engl. 49, 2238-2241
29. Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D., and Duhr, S. (2010) Protein-binding assays in biological liquids using microscale thermophoresis. Nat. Commun. 1, 100
30. Mencarelli, C., Hammels, C., Van Den Broeck, J., Losen, M., Steinbusch, H., Revert, F., Saus, J., Hopkins, D. A., De Baets, M. H., Steinbusch, H. W., and Martinez-Martinez, P. (2009) The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain. J. Chem. Neuroanat. 38, 97-105
31. Braak, H., and Braak, E. (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271-278; discussion 278-284
32. Familian, A., Zwart, B., Huisman, H. G., Rensink, I., Roem, D., Hordijk, P. L., Aarden, L. A., and Hack, C. E. (2001) Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 167, 647-654
33. Melvin, T., Kim, Y., and Michael, A. F. (1986) Amyloid P component is not present in the glomerular basement membrane in Alport-type hereditary nephritis. Am. J. Pathol. 125, 460-464
34. al-Mutlaq, H., Wheeler, J., Robertson, H., Watchorn, C., and Morley, A. R. (1993) Tissue distribution of amyloid P component as defined by a monoclonal antibody produced by immunization with human glomerular basement membranes. Histochem. J. 25, 219-227
35. Potempa, L. A., Kubak, B. M., and Gewurz, H. (1985) Effect of divalent metal ions and pH upon the binding reactivity of human serum amyloid P component, a C-reactive protein homologue, for zymosan. Preferential reactivity in the presence of copper and acidic pH. J. Biol. Chem. 260, 12142-12147
36. Chan, C. S., Winstone, T. M., and Turner, R. J. (2008) Investigating protein-protein interactions by far Westerns. Adv. Biochem. Eng. Biotechnol. 110, 195-214
37. Burgess, R. R., Arthur, T. M., and Pietz, B. C. (2000) Mapping proteinprotein interaction domains using ordered fragment ladder far Western analysis of hexahistidine-tagged fusion proteins. Methods Enzymol. 328, 141-157
38. Baltz, M. L., De Beer, F. C., Feinstein, A., and Pepys, M. B. (1982) Calcium-dependent aggregation of human serum amyloid P component. Biochim. Biophys. Acta 701, 229-236
39. Pepys, M. B., Dash, A. C., Markham, R. E., Thomas, H. C., Williams, B. D., and Petrie, A. (1978) Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin. Exp. Immunol. 32, 119-124
40. Bottazzi, B., Doni, A., Garlanda, C., and Mantovani, A. (2010) An integrated view of humoral innate immunity. Pentraxins as a paradigm. Annu. Rev. Immunol. 28, 157-183
41. Jankowsky, J. L., Younkin, L. H., Gonzales, V., Fadale, D. J., Slunt, H. H., Lester, H. A., Younkin, S. G., and Borchelt, D. R. (2007) Rodent A β modulates the solubility and distribution of amyloid deposits in transgenic mice. J. Biol. Chem. 282, 22707-22720
42. Young, L., Jernigan, R. L., and Covell, D. G. (1994) A role for surface hydrophobicity in protein-protein recognition. Protein Sci. 3, 717-729
43. Dyck, R. F., Evans, D. J., Lockwood, C. M., Rees, A. J., Turner, D., and Pepys, M. B. (1980) Amyloid P-component in human glomerular basement membrane. Abnormal patterns of immunofluorescent staining in glomerular disease. Lancet 2, 606-609
44. Hohenester, E., Hutchinson, W. L., Pepys, M. B., and Wood, S. P. (1997) Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP. J. Mol. Biol. 269, 570-578
45. Thompson, D., Pepys, M. B., Tickle, I., and Wood, S. (2002) The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose. J. Mol. Biol. 320, 1081-1086
46. Haverkate, F., Thompson, S. G., Pyke, S. D., Gallimore, J. R., and Pepys, M. B. (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349, 462-466
47. Kudo, N., Kumagai, K., Matsubara, R., Kobayashi, S., Hanada, K., Wakatsuki, S., and Kato, R. (2010) Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J. Mol. Biol. 396, 245-251
48. Kudo, N., Kumagai, K., Tomishige, N., Yamaji, T., Wakatsuki, S., Nishijima, M., Hanada, K., and Kato, R. (2008) Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc. Natl. Acad. Sci. U.S.A. 105, 488-493
49. Zhan, S. S., Veerhuis, R., Kamphorst, W., and Eikelenboom, P. (1995) Distribution of β amyloid-associated proteins in plaques in Alzheimer disease and in the non-demented elderly. Neurodegeneration 4, 291-297
50. Familian, A., Eikelenboom, P., and Veerhuis, R. (2007) Minocycline does not affect amyloid β phagocytosis by human microglial cells. Neurosci. Lett. 416, 87-91
51. Ho, J. G., Kitov, P. I., Paszkiewicz, E., Sadowska, J., Bundle, D. R., and Ng, K. K. (2005) Ligand-assisted aggregation of proteins. Dimerization of serum amyloid P component by bivalent ligands. J. Biol. Chem. 280, 31999-32008
52. Braak, H., and Braak, E. (1991) Neuropathological staging of Alzheimerrelated changes. Acta Neuropathol. 82, 239-259